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ABSTRACT 
Background: Thyroid nodule is commonly presenting finding in Otorhinolaryngology O
The nodule needs thorough eva
conflicting relationship with malignancy.
Objective: To find if thyroid nodule size is associated with malignancy
Methods and Methodology: We retrospectively review
patients who underwent thyroidectomy for presenting with thyroid nodules and had 
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histopathological evaluation available. The sizes of nodules were recorded by 
ultrasonography. The histopathological finding was recorded as benign and malignant. 
Result: There were 92 HPE reports where 51 (55.4 %) were malignant nodules and 41 (44.6 
%) were benign nodules. The mean size was 26.79 ± 13.48 mm. The mean size of benign 
lesions was 26.94 ± 15.12 cm, and malignant was 26.68± 12.16 cm. The difference was not 
statistically significant (p=0.927). 
Conclusion: Findings from the current study are suggestive that thyroid nodule size is not an 
independent predictor of malignancy. 
Keywords: Malignancy, Thyroid Nodule, Size, Ultrasonography 
This article reviewed by Dr. Adu Oluwatosin Benedict, Dr. Ram. Edited by Dr. Pradeep J., Dr. 
S Gaur. Available online 30 June 2021. 
IJMS, all rights reserved. 
 
INTRODUCTION 
A thyroid nodule is a lump within the thyroid gland that consists of unusual tissue 
growth. It is a common clinical presentation found in 5-7 % of the general population by 
palpation alone [1]. Patients with thyroid nodules are then evaluated clinically, 
biochemically, radiologically, and pathologically as 7-15% of thyroid nodules are malignant 
[2]. Hence, thyroid nodule evaluation intends to effectively categorize the nodule by cost-
effective and highly accurate diagnostic methods [3]. 
Ultrasonography is a non-invasive and reliable method to evaluate thyroid nodules. Various 
methods have been proposed to characterize thyroid nodules by USG but most commonly 
preferred are thyroid imaging reporting and data system (TI-RADS), which Horvath first 
proposed in 2009. TIRAD includes evaluating thyroid nodules as per echogenicity, shape, 
composition, margin, halo sign, and calcification [4]. The diagnostic ability of TIRADS to 
accurately distinguish between benign and malignant lesions has been found variable in 
different studies [4–6]. 
Likewise, nodule size is also an essential sonographic finding that may prove beneficial for 
risk stratification of a thyroid nodule, but the acceptance has been widely conflicting [7]. 
                                      Dr. Neeti Bhat et al. 
 www.ijmsonline.in                                                                International Journal of Medical Studies    3 
 
Few research studies have been conducted to address if nodule size is an independent 
predictor of malignancy in the Nepalese population. 
Hence, this retrospective study investigates if nodule size is an independent predictor of 
malignancy on histopathological findings in a tertiary hospital in Nepal. 
 
MATERIALS AND METHOD 
This observational analytical study was conducted at TUTH, IOM, by retrospectively 
reviewing the archive data from June 2017 to January 2019. Proforma was created to collect 
and organize data such as name, age, sex, size of the nodule on USG, and histopathological 
finding. 
We recruited 92 subjects who underwent USG followed by thyroidectomy or 
hemithyroidectomy with the final histopathological finding recorded in the database. USG 
was performed at the Department of Radiodiagnosis, and the widest diameter of the nodule 
was noted. For multiple nodules, the size of the largest nodule was documented. The 
nodules were classified as <1 cm, 1-1.9 cm, 2-2.9 cm, 3-3.9 cm and >4 cm. The 
histopathological observations were recorded as benign and malignant lesions.  
We used SPSS 23.0 software package (IBM Corp., Armonk, NY, USA) for statistical analysis. 
We calculated the malignancy rate in each subgroup of nodule according to size. T-test was 
applied to see if any difference in size exists between malignant and benign lesions. 
 
RESULT 
We recruited 92 patients in our study that underwent ultrasonography, out of which 
84.8% were females (78) and 15.2 % were males [14]. The age varied from 15–74 years, with 
the mean average age being 40.78 ± 13.48 years. The females ranged 15-74 years with mean 
age 41.02± 13.75 years, and males were of age range 18-56 years with mean age 38.21 
±12.01 years. 
In our study of 92 patients, the size of the nodule varied from 4-90 mm, and the mean size 
was 26.79 ± 13.48 mm. 
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FIGURE 1 : Nodule size distribution according 
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Figure no 2. Thyroid nodules differentiated according to gender
 
Figure no 1. Number of patients according to the nature of thyroid nodule and size 
The mean size of benign lesions was 26.94 ± 15.12 cm, a































































Figure 3 : number of patients according to the 
nature of thyroid nodule and size
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Size group HPE Frequency Mean SD p-value 
< 4 cm Benign 36 22.62 7.95 0.538 
 Malignant 45 23.88 9.87 
> 4 cm Benign 5 58 8.50 0.227 
 Malignant 6 47 1.89 
< 2 cm Benign 14 15.1879 5.60245 0.614 
 Malignant 19 14.2000 5.44089 
> 2 cm Benign 27 33.0370 14.94730 0.733 
 Malignant 32 34.0938 8.31772 
< 3 cm Benign 30 20.3543 6.55077 0.555 
 Malignant 32 19.2750 7.68786 
>3 cm Benign 11 44.9091 17.48402 0.209 
 Malignant 19 39.1579 6.87397 
Table no 2. Sizes of histopathological findings in different size groups 
 
DISCUSSION 
Different ultrasonography findings of thyroid lesions are often accredited as an 
independent predictor of malignancy. In the literature review, we found that the association 
of nodule size and malignancy potential is highly discordant [3, 8–12]. We thus conducted 
this retrospective study to evaluate if nodule size is an independent predictor of malignancy. 
Our study proffered that size doesn't independently predict malignancy in thyroid nodules. 
We observed no notable difference in the size of benign and malignant lesions. 
The mean age of our study participants was 40.783 ±13.48 years, with an age range from 
15-74 years. Likewise, there was notable female pre-dominance in our participants. Our 
finding was per existing literature [7, 12]. 
The widest nodular diameter was 4-90 mm with a mean diameter of 26.79 ±13.48 mm. 
Similar observations were made in earlier studies [3, 7].                  
Most participants had thyroid nodule size belonging to 2-2.9 cm, which is probably because 
lesion size greater than 2 cm is the likely candidate to undergo thyroidectomy. Literatures 
have ushered in the likelihood of malignancy in nodule size greater than 2 cm [13]. 
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On histopathological findings, it was observed that more than half of the lesions were 
malignant. This study is a tertiary hospital-based that explains the discovery. The discovery 
is of notable distinction from earlier studies that have reported far less malignant findings 
on histopathological reporting [14–16]. Female predilection was naturally maintained in 
both benign and malignant findings on histopathology. But the remarkable result was a 
higher risk of malignancy in histopathological findings observed in male participants. This 
finding did not correspond to earlier observations of gender disparity in thyroid carcinoma. 
Such observations could be due to the lower number of male participants [17]. 
As per size, most benign and malignant lesions belonged to a size group of 2-2.9 cm with a 
similar mean size. Variable findings were observed in similar other studies. [3, 9, 12]. On 
statistical analysis, no significant difference was observed between the sizes of benign and 
malignant lesions. Puca et al. demonstrated a significant difference in the size of a benign 
and malignant thyroid nodule [18]. No significant difference in size was observed between a 
benign and malignant group on further stratification according to size. Our impression 
correlated fairly with earlier studies and further supported the idea that thyroid nodule size 
is not an independent predictor of malignancy [11, 19]. A study by Kamran et al. proposed a 
threshold size of 2 cm, below which larger size is a predictor of malignancy. However, the 
above nodule size of 2 cm size did not accord to malignancy in the underlying lesion [3]. A 
similar disagreement was also met with a study by El-Gammal et al. [12]. Similarly, Puca et 
al. illustrated a significant difference in size in benign and malignant thyroid nodule of size 
less than 1 cm and greater than 4 cm with greater risk of malignancy with an increase in 
given size groups. Other size groups did not show a significant difference [18]. Our findings 
also refuted observations made by Cavallo et al. They demonstrated a decrease in risk of 
malignancy with an increase in size [8]. 
As we scarred lesion below and above 4 cm, we still did not observe any significant 
difference in nodule size of a benign and malignant lesion. This finding was consistent with 
previous similar works [20, 21] but contradicted other existing literature [7, 22]. 
Similarly, we did not observe any difference in the benign and malignant lesion size when 
nodules were categorized as or >2 and ≤ or>3. Hence we did not find any threshold value 
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where thyroid nodule size would be a predictor of malignancy. The findings during literature 
reviews were highly incongruous [10, 13, 19, 23, 24]. 
As per histopathological evaluation, papillary carcinoma dominated in all size groups 
followed by colloid goiter. We did not observe any increase or decrease in the prevalence of 
papillary carcinoma according to the size, which was reported by Hong et al. [19]. 
As our study was a hospital-based retrospective study, findings from this study should be 
interpreted with caution. It is plausible that other limitations, such as small sample size and 
operator dependant findings, could have influenced the results. 
We believe this study would help surgeons tackle deciding the line of management of 
patients with thyroid nodules. Further studies with a larger sample size and more rigid 
methodology should be undertaken. 
 
CONCLUSION 
Taken together, findings from the current study are suggestive that thyroid nodule size is not 
an independent predictor of malignancy. Therefore, a larger thyroid nodule is not necessarily 
a candidate for thyroidectomy for potential underlying malignancy.   
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